
Diaceutics is set to launch a diagnostic network platform that will support laboratories' efforts to provide precision medicine.
The platform, called DXRX -- The Diagnostic Network, will be launched in the fourth quarter of this year, the company said. The company plans to invest $28 million in software and data development toward the platform, which will connect more than 2,500 laboratories into a worldwide network.